These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9145739)

  • 1. Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.
    Sobel JD; Chaim W
    Clin Infect Dis; 1997 Apr; 24(4):649-52. PubMed ID: 9145739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine.
    Sobel JD; Chaim W; Nagappan V; Leaman D
    Am J Obstet Gynecol; 2003 Nov; 189(5):1297-300. PubMed ID: 14634557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boric acid for refractory Candida glabrata vaginitis.
    Dhingra S; Roseblade CK
    J Obstet Gynaecol; 2006 Aug; 26(6):584. PubMed ID: 17000521
    [No Abstract]   [Full Text] [Related]  

  • 4. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents.
    Redondo-Lopez V; Lynch M; Schmitt C; Cook R; Sobel JD
    Obstet Gynecol; 1990 Oct; 76(4):651-5. PubMed ID: 2216197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-albicans Candida Vulvovaginitis: Treatment Experience at a Tertiary Care Vaginitis Center.
    Powell AM; Gracely E; Nyirjesy P
    J Low Genit Tract Dis; 2016 Jan; 20(1):85-9. PubMed ID: 26083330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torulopsis glabrata vaginitis.
    Spinillo A; Capuzzo E; Egbe TO; Baltaro F; Nicola S; Piazzi G
    Obstet Gynecol; 1995 Jun; 85(6):993-8. PubMed ID: 7770272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azole resistant Candida glabrata vulvovaginitis treated with boric acid.
    Savini V; Catavitello C; Bianco A; Balbinot A; D'Antonio F; D'Antonio D
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):112. PubMed ID: 19619928
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
    Ray D; Goswami R; Dadhwal V; Goswami D; Banerjee U; Kochupillai N
    J Infect; 2007 Oct; 55(4):374-7. PubMed ID: 17692922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal Candida parapsilosis: pathogen or bystander?
    Nyirjesy P; Alexander AB; Weitz MV
    Infect Dis Obstet Gynecol; 2005 Mar; 13(1):37-41. PubMed ID: 16040326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy.
    Singh S; Sobel JD; Bhargava P; Boikov D; Vazquez JA
    Clin Infect Dis; 2002 Nov; 35(9):1066-70. PubMed ID: 12384840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis.
    Guaschino S; De Seta F; Sartore A; Ricci G; De Santo D; Piccoli M; Alberico S
    Am J Obstet Gynecol; 2001 Mar; 184(4):598-602. PubMed ID: 11262459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence.
    Iavazzo C; Gkegkes ID; Zarkada IM; Falagas ME
    J Womens Health (Larchmt); 2011 Aug; 20(8):1245-55. PubMed ID: 21774671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of posaconazole against Candida glabrata in a murine model of vaginitis.
    González GM; Elizondo M; Garza-González E; González JG
    Mycoses; 2011 Mar; 54(2):119-22. PubMed ID: 19811615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current therapy of vulvovaginitis.
    Rein MF
    Sex Transm Dis; 1981; 8(4 suppl):316-20. PubMed ID: 7330756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysis.
    Sood G; Nyirjesy P; Weitz MV; Chatwani A
    Infect Dis Obstet Gynecol; 2000; 8(5-6):240-3. PubMed ID: 11220485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
    Czaika V; Tietz HJ; Schmalreck A; Sterry W; Schultze W
    Mycoses; 2000; 43 Suppl 2():45-50. PubMed ID: 11291577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and clinical characteristics of mycotic vaginitis caused by Candida glabrata (Torulopsis glabrata)].
    Pawlik B; Liber Z; Warzyńska R
    Med Dosw Mikrobiol; 1989; 41(3-4):206-14. PubMed ID: 2701236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Looking for appropriateness in the cure of mixed vaginitis: the role of fenticonazole as an empiric treatment.
    Tumietto F; Posteraro B; Sanguinetti M
    Future Microbiol; 2019 Nov; 14():1349-1355. PubMed ID: 31845594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy.
    Sobel JD; Vazquez J; Lynch M; Meriwether C; Zervos MJ
    Clin Infect Dis; 1993 Jan; 16(1):93-9. PubMed ID: 8448324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.